Journal article

Parasite Viability as a Superior Measure of Antimalarial Drug Activity in Humans

M Rebelo, R Pawliw, J Gower, L Webb, H Mitchell, Z Pava, RE Watts, MP Davenport, JS McCarthy, DS Khoury

Journal of Infectious Diseases | OXFORD UNIV PRESS INC | Published : 2021

Abstract

Background: Artemisinin derivatives are the leading class of antimalarial drugs due to their rapid onset of action and rapid clearance of circulating parasites. The parasite clearance half-life measures the rate of loss of parasites from blood after treatment, and this is currently used to assess antimalarial activity of novel agents and to monitor resistance. However, a number of recent studies have challenged the use of parasite clearance to measure drug activity, arguing that many circulating parasites may be nonviable. Methods: Plasmodium falciparum-infected subjects (n = 10) in a malaria volunteer infection study were administered a single dose of artesunate (2 mg/kg). Circulating paras..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Australian Research Council


Funding Acknowledgements

This work was supported by the Australian Research Council (grants DP120100064 and DP180103875 to M. P. D. and D. S. K.), the National Health and Medical Research Council (NHMRC) of Australia (grants 1141921 to D. S. K., 1080001 and 1173027 to M. P. D., and 1135955 and 1132975 to J. S. M.), and Medicines for Malaria Venture (funding for the clinical trial from which the study data was derived).